François-Henri Boissel, CEO, will take part in an open forum discussion during “Current and future options for virtual trials in early medicines development” session 1 on May 16 at 10 AM
Live
Stay informed about what's happening at Nova#drugR&D #insilicomedicine #systemsbiology #biomodeling #machinelearning
BIO 2019
The BIO International Convention (BIO) attracts 16,000+ biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships.